Prognosis and Toxicity Stratified by Best Tumor Burden Change in Japanese Patients With Advanced Melanoma Treated With First-Line Programmed Cell Death Protein 1 Monotherapy.

Although the difference in the incidence of grade ≥ 3 irAEs did not reach statistical significance, this observation remains clinically relevant, as even low‐grade irAEs may serve as an indicator of an active and effective immune response.

also in 111,027 other papers